Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions

Author's Avatar
Mar 11, 2021
Article's Main Image

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced the successful launch of its 2021 MIDD+ Scientific Conference, a two-day event focused on delivering customized modeling and simulation content specifically for pharmaceutical scientists and their organizations. Tracks included dedicated sessions covering all stages of the drug development process including Discovery, Pre-clinical, First in Human (FIH)/Phase I through Post-Approval and Generics.